MyFinsight
Home
Blog
About
Contact
Maturities of marketable
securities
$5,406,000
Net cash provided by
investing activities
$5,400,982
Effect of exchange rate
changes on cash, cash...
$20,103
Canceled cashflow
$5,018
Net increase
(decrease) in cash, cash...
$2,258,910
Canceled cashflow
$3,162,174
Purchase of property and
equipment
$5,018
Stock-based compensation
$209,510
Prepaid collaboration
expenses/accrued collaboration...
-$176,368
Investment income and fair
value adjustments on...
-$54,395
Reduction of operating
lease right-of-use...
$31,416
Depreciation and
amortization
$10,563
Change in fair value of
contingent consideration
$7,427
Exercise of warrants
$170
Net cash used in
operating activities
-$3,161,332
Net cash used in
financing activities
-$842
Canceled cashflow
$489,679
Canceled cashflow
$170
Net loss
-$2,417,984
Accrued expenses
-$389,063
Accounts payable
-$303,026
Tax and other
receivables
$235,647
Taxes paid related to
net share...
$1,012
Prepaid expenses and
other current assets
$221,213
Operating lease
liabilities
-$41,953
Other assets
$27,706
Collaboration receivables
$21,483
Back
Back
Cash Flow
KIORA PHARMACEUTICALS INC (KPHMW)
KIORA PHARMACEUTICALS INC (KPHMW)
source: myfinsight.com